Subjects with Moderate to Severe Endometriosis-Associated Pain

Status: open

A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethinedrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain

Treatment for Endometriosis

Contact Us Or call 251-415-1598

Description

A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult pre-menopausal female subjects.

Sponsors

This trial is sponsored by AbbVie.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.